Trends and predictors in methadone maintenance treatment dropout in Shanghai, China: 2005-2011

Current Medical Research and Opinion

Volumn 29, Issue 7, 2013, Pages 731-738

  Ren, Jinma ^a   Ning, Zhen ^b   Asche, Carl V ^a,c   Zhuang, Minghua ^b   Kirkness, Carmen S ^a   Ye, Xiangyang ^d   Fu, Jie ^b   Pan, Qichao ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

Dropout; Methadone maintenance treatment; Predictors; Survival analysis; Tapering off; Trend

Indexed keywords

METHADONE; OPIATE;

ADULT; ARTICLE; CHINA; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; NEEDLE; OPIATE ADDICTION; PREDICTION; RETROSPECTIVE STUDY; URINALYSIS; URINE;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; CHINA; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; MEDICATION ADHERENCE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84880287089     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2013.796284     Document Type: Article

References (31)

1. Aceijas C, Stimson GV, Hickman M, et al. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004;18:2295-303
2. Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007;18:352-8
3. China AIDS Response Progress Report. Ministry of Health of the People's Republic of China, 2012. Available at: http://aidsdatahub.org/en/reference- librarycols2/item/24194-ungass-country-progress-report-china-state-council-aids- working-committee-office-china-2012 [Last accessed 22 January 2013]
4. Over 1.4 million drug users were registered and about 70,000 had not relapsed for over three years. Narcotics Control Bureau of the Ministry of Public Security, 2010. Available at: http://www.mps.gov.cn/n16/n80209/n80421/ 2636872.html [Last accessed 22 January 2013]
5. Zhan D, Li D. Analysis of HIV, syphilis and HBV infections in sera of 1639 heroin addicts. Chin J AIDS STD 2003;9:98-9
6. Huang H, Zhou H, Zheng X. A study on HBV HCV infection in 2260 cases with intravenous infection heroin addicts. Disease Surveillance 2000;15: 128-30
7. The report of national notifiable infectious diseases issued by the Ministry of Health in December 2011. Ministry of Health of the People's Republic of China, 2011. Available at: http://www.moh.gov.cn/mohjbyfkzj/s3578/201201/ 53904.shtml [Last accessed 3 December 2012]
8. Liu L, Wei L. Epidemiology of hepatitis C virus. Infectious Disease Information 2007;20:261-4
9. Payte JT. A brief history of methadone in the treatment of opioid dependence: a personal perspective. J Psychoactive Drugs 1991;23:103-7
10. Ward J, Mattick RP, Hall W. The effectiveness of methadone maintenance treatment: an overview. Drug Alcohol Rev 1994;13:327-35
11. Haig T. Randomized controlled trial proves effectiveness of methadone maintenance treatment in prison. Canadian HIV/AIDS Policy & Law Review/Canadian HIV/AIDS Legal Network 2003;8:48
12. Pang L, Hao Y, Mi G, et al. Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS 2007;21(Suppl 8):S103-7
13. MacArthur GJ, Minozzi S, Martin N, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ 2012;345:e5945
14. Yin W, Hao Y, Sun X, et al. Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol 2010;39(Suppl 2):ii29-37
15. Cao X, Wu Z. Methadone maintenance treatment as an HIV prevention strategy: a research update. Chin J AIDS STD 2011;17:196-9
16. WHO, UNODC, UNAIDS. Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention: position paper. Geneva: WHO, 2004
17. Qian HZ, Schumacher JE, Chen HT, et al. Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications. Harm Reduction J 2006;3:4
18. Gu J, Xu H, Lau JT et al. Misconceptions predict dropout and poor adherence prospectively among newly admitted first-time methadone maintenance treatment clients in Guangzhou, China. Addiction 2012;107:1641-9
19. Shanghai Statistical Yearbook 2011. Shanghai Municipal Statistics Bureau. Available at: http://www.stats-sh.gov.cn/data/toTjnj.xhtml?y=2011e [Last accessed 16 December 2012]
20. Mao Y, Wu Z, Poundstone K, et al. Development of a unified web-based national HIV/AIDS information system in China. Int J Epidemiol 2010; 39(Suppl 2):ii79-89
21. Che Y, Assanangkornchai S, McNeil E, et al. Predictors of early dropout in methadone maintenance treatment program in Yunnan province, China. Drug Alcohol Rev 2010;29:263-70
22. Bao YP, Liu ZM, Epstein DH, et al. A meta-analysis of retention in methadone maintenance by dose and dosing strategy. Am J Drug Alcohol Abuse 2009;35:28-33
23. Brady TM, Salvucci S, Sverdlov LS, et al. Methadone dosage and retention: an examination of the 60 mg/day threshold. J Addictive Diseases 2005;24: 23-47
24. Magura S, Nwakeze PC, Demsky SY. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998;93:51-60
25. Caplehorn JR, Bell J. Methadone dosage and retention of patients in maintenance treatment. Med J Aust 1991;154:195-9
26. Maremmani I, Nardini R, Zolesi O, et al. Methadone dosages and therapeutic compliance during a methadone maintenance program. Drug Alcohol Dependence 1994;34:163-6
27. Hser YI, Li J, Jiang H, et al. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction 2011;106:1801-9
28. Wu F, Peng CY, Jiang H, et al. Methadone maintenance treatment in China: perceived challenges from the perspectives of service providers and patients. J Public Health 2012;1-7. doi:10.1093/pubmed/fds079. Available at: http://jpubhealth.oxfordjournals.org/content/early/2012/09/19/pubmed.fds079.long
29. Holmes D. Prescription drug addiction: the treatment challenge. Lancet 2012;379:17-18
30. Calsyn DA, Malcy JA, Saxon AJ. Slow tapering from methadone maintenance in a program encouraging indefinite maintenance. J Substance Abuse Treatment 2006;30:159-63
31. Wu Z, Sullivan SG, Wang Y, et al. Evolution of China's response to HIV/AIDS. Lancet 2007;369:679-90